The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
The mechanisms of action of gabapentin and pregabalin
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Novel Anticonvulsant Drug, Gabapentin (Neurontin), Binds to the α2δ Subunit of a Calcium Channel
Gee, N. S., Brown, J. P., Dissanayake, V. U. K., Offord, J., Thurlow, R., & Woodruff, G. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.10.5768 · Cited by 1,181
A summary of mechanistic hypotheses of gabapentin pharmacology
Taylor, C. P., Gee, N. S., Su, T.-Z., Kocsis, J. D., Welty, D. F., Brown, J. P., Dooley, D. J., Boden, P., & Singh, L. (1998) · Epilepsy Research · doi:10.1016/s0920-1211(97)00084-3 · Cited by 774
Pregabalin Pharmacology and Its Relevance to Clinical Practice
Ben‐Menachem, E. (2004) · Epilepsia · doi:10.1111/j.0013-9580.2004.455003.x · Cited by 542
Inhibition of neuronal Ca2+ influx by gabapentin and pregabalin in the human neocortex
Fink, K., Dooley, D. J., Meder, W. P., Suman-Chauhan, N., Duffy, S., Clusmann, H., & Göthert, M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00172-1 · Cited by 496
Fehrenbacher, J. C., Taylor, C. P., & Vasko, M. R. (2003) · Pain · doi:10.1016/s0304-3959(03)00173-8 · Cited by 336
3-Substituted GABA analogs with central nervous system activity: A review
Bryans, J. S., & Wustrow, D. J. (1999) · Medicinal Research Reviews · doi:10.1002/(sici)1098-1128(199903)19:2<149::aid-med3>3.0.co;2-b · Cited by 297
Gabapentin Adjunctive Therapy in Neuropathic Pain States
Rosner, H., Rubin, L., & Kestenbaum, A. (1996) · The Clinical Journal of Pain · doi:10.1097/00002508-199603000-00010 · Cited by 293
The effect of gabapentin on brain gamma‐aminobutyric acid in patients with epilepsy
Petroff, O. A. C., Rothman, D. L., Behar, K. L., Lamoureux, D., & Mattson, R. H. (1996) · Annals of Neurology · doi:10.1002/ana.410390114 · Cited by 285
Sutton, K. G., Martin, D. J., Pinnock, R. D., Lee, K., & Scott, R. H. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704439 · Cited by 240
Structure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein
Belliotti, T. R., Capiris, T., Ekhato, I. V., Kinsora, J. J., Field, M. J., Heffner, T. G., Meltzer, L. T., Schwarz, J. B., Taylor, C. P., Thorpe, A. J., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049762l · Cited by 212
Maneuf, Y. P., Hughes, J., & McKnight, A. T. (2001) · Pain · doi:10.1016/s0304-3959(01)00316-5 · Cited by 184
Dooley, D. J., Donovan, C. M., Meder, W. P., & Whetzel, S. Z. (2002) · Synapse · doi:10.1002/syn.10094 · Cited by 180
Su, T., Lunney, E. A., Campbell, G., & Oxender, D. L. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052125.x · Cited by 175
Gabapentin actions on ligand- and voltage-gated responses in cultured rodent neurons
Rock, D. M., Kelly, K. M., & Macdonald, R. L. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90023-z · Cited by 174
Fink, K., Meder, W., Dooley, D. J., & Göthert, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703380 · Cited by 169
Ng, G., Bertrand, S. S., Sullivan, R. J., Éthier, N., Wang, J. P., Yergey, J. A., Belley, M. L., Trimble, L. A., Bateman, K. P., Alder, L., et al. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.1.144 · Cited by 153
Martin, D. J., McClelland, D. E., Herd, M. B., Sutton, K. G., Hall, M. D., Lee, K., Pinnock, R. D., & Scott, R. H. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00181-2 · Cited by 148
Dual effects of gabapentin and pregabalin on glutamate release at rat entorhinal synapses in vitro
Cunningham, M. O., Woodhall, G. L., Thompson, S. E., Dooley, D. J., & Jones, R. S. G. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03625.x · Cited by 135
Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents
Danielsson, B. R. G., Lansdell, K., Patmore, L., & Tomson, T. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.10.002 · Cited by 130
Gabapentin Increases the Hyperpolarization‐activated Cation Current Ih in Rat CA1 Pyramidal Cells
Surges, R., Freiman, T. M., & Feuerstein, T. J. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.36802.x · Cited by 130
Structural requirement of the calcium-channel subunit α2δ for gabapentin binding
Wang, M., Offord, J., Oxender, D. L., & Su, T. (1999) · Biochemical Journal · doi:10.1042/bj3420313 · Cited by 129
Gabapentin is not a GABAB receptor agonist
Lanneau, C., Green, A., Hirst, W. D., Wise, A., Brown, J. T., Donnier, E., Charles, K. J., Wood, M. D., Davies, C. H., & Pangalos, M. N. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00140-x · Cited by 129
Schumacher, T. B., Beck, H., Steinhäuser, C., Schramm, J., & Elger, C. E. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01387.x · Cited by 129
Errante, L. D., & Petroff, O. A. C. (2003) · Seizure · doi:10.1016/s1059-1311(02)00295-9 · Cited by 123
The Anticonvulsant Gabapentin (Neurontin) Does Not Act through γ-Aminobutyric Acid-B Receptors
Jensen, A. A., Mosbacher, J., Elg, S., Lingenhoehl, K., Lohmann, T., Johansen, T. N., Abrahamsen, B., Mattsson, J. P., Lehmann, A., Bettler, B., et al. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.6.1377 · Cited by 108
McClelland, D. E., Evans, R. M., Barkworth, L., Martin, D. J., & Scott, R. H. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-14 · Cited by 97
3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents
Taylor, C. P., Vartanian, M. G., Andruszkiewicz, R., et al. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90044-t · Cited by 96
Bertrand, S. S., Ng, G., Purisai, M. G., Wolfe, S. E., Severidt, M. W., Nouel, D., Robitaille, R., Low, M. J., O’Neill, G. P., Metters, K. M., et al. (2001) · PubMed · Cited by 92
Su, T. Z., Feng, M. R., & Weber, M. L. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.082255 · Cited by 92
Bayer, K., Ahmadi, S., & Zeilhofer, H. U. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2003.11.010 · Cited by 90
van Hooft, J. A., Dougherty, J. J., Endeman, D., Nichols, R. A., & Wadman, W. J. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02044-7 · Cited by 85
Wamil, A. W., & McLean, M. J. (1994) · Epilepsy Research · doi:10.1016/0920-1211(94)90074-4 · Cited by 85
Honmou, O., Kocsis, J. D., & Richerson, G. B. (1995) · Epilepsy Research · doi:10.1016/0920-1211(94)00076-9 · Cited by 85
Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum.
Götz, E., Tj, F., Lais, A., & Dk, M. (1993) · PubMed · Cited by 81
Brown, J. T., & Randall, A. D. (2005) · Synapse · doi:10.1002/syn.20115 · Cited by 80
Gabapentin and vigabatrin increase GABA in the human neocortical slice
Errante, L. D., Williamson, A., Spencer, D. D., & Petroff, O. A. C. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00034-7 · Cited by 78
Stefani, A., Spadoni, F., Giacomini, P., Lavaroni, F., & Bernardi, G. (2001) · Epilepsy Research · doi:10.1016/s0920-1211(00)00201-1 · Cited by 77
Xie, X., Dale, T. J., John, V. H., Cater, H. L., Peakman, T. C., & Clare, J. J. (2001) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004240000448 · Cited by 71
Gabapentin actions on N -methyl-D-aspartate receptor channels are protein kinase C-dependent
Gu, Y., & Huang, L.-Y. M. (2001) · Pain · doi:10.1016/s0304-3959(01)00297-4 · Cited by 57
Suárez, L. M., Suárez, F., Olmo, N. D., Ruiz, M., González-Escalada, J. R., & Solís, J. M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03832.x · Cited by 56
Freiman, T. M., Kukolja, J., Heinemeyer, J., et al. (2001) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100100408 · Cited by 54
Neurochemical actions of gabapentin in mouse brain
Leach, J. P., Sills, G. J., Butler, E., Forrest, G., Thompson, G. G., & Brodie, M. J. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)01034-6 · Cited by 49
Self-citationKelly, K. (1998) · Neuropsychobiology · doi:10.1159/000026529 · Cited by 49
Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices
Parker, D. A. S., Ong, J. A., Marino, V., & Kerr, D. I. B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.029 · Cited by 47
Gabapentin: A unique anti-epileptic agent
Dougherty, J. A., & Rhoney, D. H. (2001) · Neurological Research · doi:10.1179/016164101101199414 · Cited by 43
Xiong, Z., & Stringer, J. L. (1997) · Epilepsy Research · doi:10.1016/s0920-1211(97)00022-3 · Cited by 42
Maneuf, Y. P., Blake, R., Andrews, N. A., & McKnight, A. T. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705579 · Cited by 36
Stringer, J. L., & Lorenzo, N. (1999) · Epilepsy Research · doi:10.1016/s0920-1211(98)00083-7 · Cited by 20
Cited by
A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin
Bockbrader, H. N., Wesche, D., Miller, R., Chapel, S., Janiczek, N., & Burger, P. (2010) · Clinical Pharmacokinetics · doi:10.2165/11536200-000000000-00000 · Cited by 690
Clarke, H., Bonin, R. P., Orser, B. A., Englesakis, M., Wijeysundera, D. N., & Katz, J. (2012) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e318249d36e · Cited by 481
Verret, M., Lauzier, F., Zarychanski, R., Perron, C., Savard, X., Pinard, A.-M., Leblanc, G., Cossi, M.-J., Neveu, X., Turgeon, A. F., et al. (2020) · Anesthesiology · doi:10.1097/aln.0000000000003428 · Cited by 457
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
Atkin, T., Comai, S., & Gobbi, G. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014381 · Cited by 391
Trigeminal neuralgia: An overview from pathophysiology to pharmacological treatments
Gambeta, E., Chichorro, J. G., & Zamponi, G. W. (2020) · Molecular Pain · doi:10.1177/1744806920901890 · Cited by 376
Metadata
- Authors
- SILLS, G.
- Venue
- Current Opinion in Pharmacology
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 6
- Issue
- 1
- Pages
- 108-113
- ISSN
- 1471-4892 (ISSN-L)
- OpenAlex
- W1965829294
- Cited by
- 671
- References
- 49
- FWCI
- 13.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.